Enzymatic Modification Process for Functional Egg Protein and Peptide Ingredients

Overview

A scalable enzymatic modification process that produces differentiated egg protein and peptide ingredients from egg white, yolk, and whole-egg powders. The process applies food-grade enzymes under mild conditions to selectively modify amino acids and control hydrolysis, increasing charge density and structural flexibility. These changes reduce protein aggregation, enhancing solubility and thermal stability while improving other functional properties. Recent studies demonstrate protein solubility increasing from 20% to 92% and up to 80% reduction in off-flavors, with controlled hydrolysis preserving digestibility and limiting bitterness.

The resulting ingredients are suited for food and beverage applications where egg proteins provide nutrition, structure, and texture, with improved performance in formulations requiring high solubility, heat stability, and clean flavor profiles.

Technical specifications

The process uses two complementary enzyme classes: non-hydrolyzing enzymes for selective amino acid modification and hydrolyzing enzymes for controlled hydrolysis. Key parameters include:

• Mild reaction conditions (pH 6–8, 40–60°C), below egg-protein denaturation temperatures
• Controlled hydrolysis at degree of hydrolysis (DH) 1–8% to balance functionality and digestibility while minimizing bitterness
• Enzyme concentration, reaction time, temperature, and pH optimized for each egg fraction
• Optional membrane fractionation to generate multiple value-added ingredient streams

Validation covers proximate composition; structural properties (zeta potential, particle size distribution, protein profile, turbidity); functional properties (solubility, heat stability, emulsification, foaming, gelation); nutritional quality (amino acid composition, in vitro protein digestibility); and off-flavor profiling.

Technology readiness level

The enzymatic approach has been validated in recent studies, showing protein solubility improvement from 20% to 92% and off-flavor reduction up to 80%. Current development includes characterization of untreated egg proteins, process optimization for enzyme treatment parameters, and evaluation of optimized ingredients against native proteins and controls. Scale-up production planning is a next step, placing the technology at an early-stage (laboratory/pilot) development level.